ARCHIVES

Blincyto Demonstrates Response In Minimal Residual Disease ALL

This article is from The Cancer Letter archive.

Vol. 37 No. 12 | December 26, 2014

Download PDF Visit The Full Archive

Related Articles

Choice Of Reconstruction Can Depend On Who Consults

October 29, 2010

Prevention & Control Study Section In DRG Requested By NCI

February 8, 1991

GM Corp, to Reimburse Marrow Transplants for Breast Cancer

March 15, 1996

Bush Appoints Niederhuber Chairman of NCAB

August 2, 2002

Protein May Link Obesity To Cancer Aggressiveness

February 22, 2013

Interferon Interest Zooms; NCI Awarding Production Contracts, Proceeds With Plans For Clinical Trials

March 14, 1980